A Registry to Investigate Real-world Natural History, Impact of Therapies and Patterns of Progression of AL Amyloidosis (ReAL)

Fondazione IRCCS Policlinico San Matteo di Pavia1 个研究点分布在 1 个国家目标入组 5,000 人2020年2月27日

适应症AL Amyloidosis

概览

阶段: 不适用
干预措施: 未指定
疾病 / 适应症: AL Amyloidosis
发起方: Fondazione IRCCS Policlinico San Matteo di Pavia
入组人数: 5000
试验地点: 1
主要终点: Creation of a registry of patients with AL amyloidosis
状态: 招募中
最后更新: 16天前

概览研究者入排标准结局指标研究点相似试验

概览

简要总结

The purpose of this protocol is to generate a large registry of patients with AL amyloidosis.

详细描述

Thanks to this registry, it will be possible to collect data at diagnosis and during follow up, in order to be able to describe the natural history of AL amyloidosis in a real-world setting and to define and validate prognostic models, response and relapse criteria applicable at any point of the disease.

注册库

clinicaltrials.gov

开始日期

2020年2月27日

结束日期

2027年5月1日

最后更新

16天前

研究类型

Observational

性别

All

研究者

发起方

Fondazione IRCCS Policlinico San Matteo di Pavia

责任方

Principal Investigator

主要研究者

Giovanni Palladini

Principal Investigator

Fondazione IRCCS Policlinico San Matteo di Pavia

入排标准

入选标准

•diagnosis of systemic AL amyloidosis;
•treatment-naïve (pre-treatment data collected at participating center available for retrospective part);
•age ≥18 years;
•ability to understand and willingness to sign an informed consent (patients who already sign informed consent for clinical data to be used in retrospective analyses will be accepted);
•planned (or ongoing) follow-up at participating center.